This alliance seeks to accelerate the delivery of innovative hematologic oncology treatments to patients.
Read more
La Clínica Universidad de Navarra, con participación de investigadores del Cima Universidad de Navarra, ha liderado el proyecto BRAVE, que combina bioingeniería y medicina regenerativa para desarro...
Read more
Behind every scientific breakthrough and every patient receiving successful treatment, there’s a fundamental pillar, often invisible to the general public: the quality and safety of manufacturing fa...
Read more
Unlike conventional treatments that directly target tumors, immunotherapy aims to boost the patient’s own immune defenses. Think of it as specialized training for your immune system—teaching it to...
Read more
Since 2004, his laboratory has intensely studied cardiac progenitor cells, their origins and their therapeutic potential. Marbán’s discoveries make up the base of Deramiocel, a cell therapy product...
Read more
First patient received bilateral administration of NRTX-1001; no significant surgical complications or adverse events reported to date
Read more
Investigadores del Cima confirman que la administración intratumoral del virus Delta-24-RGD y la activación de células dendríticas abren una vía terapéutica para los pacientes con glioma difuso ...
Read more
It has been developed a new cell therapy based on CAR-T cells designed to simultaneously target two specific markers of T-cell acute lymphoblastic leukemia (T-ALL): the proteins CD1a and CCR9.
Read more
After receiving chemotherapy and radiotherapy, the patient also began immunotherapy with immune checkpoint inhibitors (ICI), a treatment that boosts the ability of lymphocytes to recognise and combat ...
Read more
El estudio, liderado por el CSIC, demuestra que el deterioro asociado a la edad de los linfocitos T CD4 debilita la barrera intestinal, y favorece la inflamación crónica y la senescencia celular
Read more
A study led by the Clínic-IDIBAPS reveals that the microbiota can predict and enhance patient response to one of the most innovative immunotherapies against cancer.
Read more
The funds come from new investors like the EIC Fund and CDTI Innvierte, as well as from existing investors AdBio Partners, Columbus Venture Partners, Invivo Partners and Takeda Ventures, which continu...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
